Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - ...
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...
Aiming to facilitate large-scale indigenous manufacturing, this device will secure regulatory approvals, and facilitate the ...
After the city reduced its funding award to the Douglas County Housing Stabilization Collaborative, the organization that ...
It comes after weeks of criticism from pub bosses, industry chiefs and politicians over changes to business rates in the ...
Places like Breckenridge still get money from out-of-towners, but the dip while the economy is on shaky footing has towns ...
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will outline the pillars of its growing global oncology leadership during its presentation today at the 44 th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback